Stocks at Fresh 13-Month Highs as Investors Eye the Fed, and Biogen’s Latest Boardroom Drama 6/13/23

Markets added to the week’s gains, with the S&P and Nasdaq both closing at their highest levels since last April. The Dow at its best since February 13. But will tomorrow’s Fed decision take the air out of the rally? Plus a shake up on Biogen’s board raising eyebrows as the company’s Alzheimer’s treatment draws questions. What it all means for the stock. Fast Money Disclaimer  Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.